Numeta G13E Infusionsvätska, emulsion

Land: Sverige

Språk: svenska

Källa: Läkemedelsverket (Medical Products Agency)

Bipacksedel Bipacksedel (PIL)
18-10-2019
Produktens egenskaper Produktens egenskaper (SPC)
18-10-2019

Aktiva substanser:

alanin; arginin; asparaginsyra; cystein; fenylalanin; glukosmonohydrat; glutaminsyra; glycin; histidin; isoleucin; kalciumkloriddihydrat; kaliumacetat; leucin; lysinmonohydrat; magnesiumacetattetrahydrat; metionin; natriumglycerofosfat, hydratiserat; olivolja, raffinerad; ornitinhydroklorid; prolin; serin; sojaolja, raffinerad; taurin; treonin; tryptofan; tyrosin; valin

Tillgänglig från:

Baxter Medical AB

ATC-kod:

B05BA10

INN (International namn):

alanine; arginine; aspartic acid; cysteine; phenylalanine; glukosmonohydrat; glutamic acid; glycine; histidine; isoleucine; kalciumkloriddihydrat; acid; leucine; lysinmonohydrat; magnesiumacetattetrahydrat; methionine; natriumglycerofosfat, hydrated; olive oil, refined; ornitinhydroklorid; proline; serine; soybean oil, refined; taurine; threonine; tryptophan; tyrosine; valine

Läkemedelsform:

Infusionsvätska, emulsion

Sammansättning:

metionin 1,4 mg Aktiv substans; ornitinhydroklorid 1,85 mg Aktiv substans; fenylalanin 2,45 mg Aktiv substans; prolin 1,75 mg Aktiv substans; serin 2,33 mg Aktiv substans; taurin 0,35 mg Aktiv substans; treonin 2,16 mg Aktiv substans; tryptofan 1,17 mg Aktiv substans; tyrosin 0,45 mg Aktiv substans; valin 4,43 mg Aktiv substans; glukosmonohydrat 550 mg Aktiv substans; histidin 2,21 mg Aktiv substans; glycin 2,33 mg Aktiv substans; glutaminsyra 5,83 mg Aktiv substans; cystein 1,1 mg Aktiv substans; lysinmonohydrat 7,2 mg Aktiv substans; leucin 5,83 mg Aktiv substans; isoleucin 3,9 mg Aktiv substans; alanin 4,66 mg Aktiv substans; natriumglycerofosfat, hydratiserat 6,15 mg Aktiv substans; magnesiumacetattetrahydrat 0,63 mg Aktiv substans; kalciumkloriddihydrat 3,45 mg Aktiv substans; kaliumacetat 3,83 mg Aktiv substans; sojaolja, raffinerad 25 mg Aktiv substans; glycerol Hjälpämne; olivolja, raffinerad 100 mg Aktiv substans; asparaginsyra 3,5 mg Aktiv substans; arginin 4,89 mg Aktiv substans

Receptbelagda typ:

Receptbelagt

Produktsammanfattning:

Förpacknings: Trekammarpåse, 1 x 300 ml; Trekammarpåse, 10 x 300 ml

Bemyndigande status:

Godkänd

Tillstånd datum:

2016-05-12

Bipacksedel

                                PACKAGE LEAFLET: INFORMATION FOR THE USER
NUMETA G13E EMULSION FOR INFUSION
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your child’s doctor,
pharmacist, or nurse.
-
If your child gets any side effects, talk to your child’s doctor or
nurse. This includes any
possible side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
:
1.
What Numeta G13E is and what it is used for
2.
What you need to know before your child is given Numeta G13E
3.
How Numeta G13E is given
4.
Possible side effects
5.
How to store Numeta G13E
6.
Contents of the pack and other information
1.
WHAT NUMETA G13E IS AND WHAT IT IS USED FOR
Numeta G13E is a specialised nutrition emulsion designed for preterm
newborns. It is given
through a tube which is placed in your child’s vein, when your child
is not able to eat all of his or
her nutrition by mouth.
Numeta is presented in the form of a three chamber bag in which the
separate chambers contain:
a 50 % glucose solution
a 5.9% paediatric amino acid solution, with electrolytes
a 12.5% lipid (fat) emulsion
Depending on your child’s needs, two or three of these solutions are
mixed together in the bag
before it is given to your child.
Numeta G13E must only be used under medical supervision.
2.
WHAT YOU NEED TO KNOW BEFORE YOUR CHILD IS GIVEN NUMETA G13E
YOUR CHILD SHOULD NOT BE GIVEN NUMETA G13E, IN THE FOLLOWING CASES:
WITH THE GLUCOSE AND AMINO ACID/ELECTROLYTE SOLUTIONS MIXED TOGETHER
IN THE BAG (“2 IN 1”):
-
If your child is allergic to egg, soya, peanuts or to any ingredient
of this medicine or
component of the container (listed in section 6).
-
If your child’s body has problems using building blocks of protein.
-
If your child has high concentrations of any of the electrolytes
included in Numeta G13E
in their blood.
-
Numeta G13E (or other calcium containing solutions) must not be given
at the
                                
                                Läs hela dokumentet
                                
                            

Produktens egenskaper

                                Page
1
of
26
SUMMARY OF PRODUCT CHARACTERISTICS
1. NAME OF THE MEDICINAL PRODUCT
Numeta G13E emulsion for infusion.
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
This medicinal product is presented in the form of a three chamber
bag. Each bag
contains a sterile non-pyrogenic combination of a glucose solution, a
paediatric amino
acids solution, with electrolytes, and a lipid emulsion, as described
below.
CONTAINER SIZE
50% GLUCOSE SOLUTION
5.9% AMINO ACIDS SOLUTION
WITH ELECTROLYTES
12.5% LIPID EMULSION
300 mL
80 mL
160 mL
60 mL
If lipid administration is undesirable, the design of the bag allows
the possibility to
activate only the peel seal between the amino acids/electrolytes and
glucose
chambers, leaving the peel seal between the amino acids and lipid
chambers intact.
The content of the bag can subsequently be infused with or without
lipids. The
composition of the drug product after mixing of the two (amino acids
and glucose, 2
chamber bag, 240 mL solution) or three (amino acids, glucose and
lipid, 3 chamber
bag, 300 mL emulsion) chambers are provided in the following table.
COMPOSITION
ACTIVE SUBSTANCE
ACTIVATED 2CB
(240 ML)
ACTIVATED 3CB
(300 ML)
AMINO ACID CHAMBER
Alanine
0.75 g
0.75 g
Arginine
0.78 g
0.78 g
Aspartic acid
0.56 g
0.56 g
Cysteine
0.18 g
0.18 g
Glutamic acid
0.93 g
0.93 g
Glycine
0.37 g
0.37 g
Histidine
0.35 g
0.35 g
Isoleucine
0.62 g
0.62 g
Leucine
0.93 g
0.93 g
Lysine monohydrate
(equivalent to Lysine)
1.15 g
(1.03 g)
1.15 g
(1.03 g)
Methionine
0.22 g
0.22 g
Ornithine hydrochloride
(equivalent to Ornithine)
0.30 g
(0.23 g)
0.30 g
(0.23 g)
Phenylalanine
0.39 g
0.39 g
Proline
0.28 g
0.28 g
Serine
0.37 g
0.37 g
Taurine
0.06 g
0.06 g
Threonine
0.35 g
0.35 g
Page
2
of
26
COMPOSITION
ACTIVE SUBSTANCE
ACTIVATED 2CB
(240 ML)
ACTIVATED 3CB
(300 ML)
Tryptophan
0.19 g
0.19 g
Tyrosine
0.07 g
0.07 g
Valine
0.71 g
0.71 g
Potassium acetate
0.61 g
0.61 g
Calcium chloride dihydrate
0.55 g
0.55 g
Magnesium acetate tetrahydrate
0.10 g
0.10 g
Sodium glycerophosphate hydrated
0.98 g
0.98 g
GLUCOSE CHAMBER
Glucose 
                                
                                Läs hela dokumentet
                                
                            

Dokument på andra språk

Bipacksedel Bipacksedel engelska 14-09-2023
Produktens egenskaper Produktens egenskaper engelska 14-09-2023
Offentlig bedömningsrapport Offentlig bedömningsrapport engelska 12-05-2016